Vandetanib

Grey

Brand Name(s):Caprelsa, Zactima

Indication:Aggressive and symptomatic medullary thyroid cancer (MTC) in patients with unresectable locally advanced or metastatic disease

Rationale:1

Considered:Oct-10

Review Date:Jan-24

Comments:
NICE TA550
Vandetanib for treating medullary
thyroid cancer
December 2018